These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16315779

  • 1. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M, Deubner D, Saltini C.
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [Abstract] [Full Text] [Related]

  • 2. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
    Amicosante M, Berretta F, Rossman M, Butler RH, Rogliani P, van den Berg-Loonen E, Saltini C.
    Respir Res; 2005 Aug 14; 6(1):94. PubMed ID: 16098233
    [Abstract] [Full Text] [Related]

  • 3. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.
    Eur Respir J; 2001 Oct 14; 18(4):677-84. PubMed ID: 11716174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.
    J Immunol; 2005 Nov 15; 175(10):7029-37. PubMed ID: 16272364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.
    J Immunol; 2003 Dec 15; 171(12):6910-8. PubMed ID: 14662898
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT, Parsons CE, Fontenot AP, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Newman LS.
    Am J Respir Cell Mol Biol; 2004 Jul 15; 31(1):122-30. PubMed ID: 14975942
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
    McCanlies EC, Schuler CR, Kreiss K, Frye BL, Ensey JS, Weston A.
    J Occup Environ Med; 2007 Apr 15; 49(4):446-52. PubMed ID: 17426528
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.
    Occup Environ Med; 2011 Jul 15; 68(7):487-93. PubMed ID: 21186201
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM, Buchner V, Field RW, Scott BL.
    Rev Environ Health; 2009 Jul 15; 24(2):75-115. PubMed ID: 19658317
    [Abstract] [Full Text] [Related]

  • 19. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP.
    Proc Am Thorac Soc; 2010 May 15; 7(2):126-9. PubMed ID: 20427584
    [Abstract] [Full Text] [Related]

  • 20. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
    Weston A, Snyder J, McCanlies EC, Schuler CR, Andrew ME, Kreiss K, Demchuk E.
    Mutat Res; 2005 Dec 30; 592(1-2):68-78. PubMed ID: 16054169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.